Project Details
Short title | A Phase III Randomized Study Of TLK286 Versus Doxil/Caelyx Or Hycamtin As A Third-Line Therapy In Platinum Refractory Or Resistant Ovarian Cancer |
---|---|
Status | Finished |
Effective start/end date | 1/03/04 → 28/02/07 |
Funding
- TELIK INC